Expression of B23/Nucleophosphamine Nonribosomal Nucleolar Protein in Smooth Muscle Tumors of the Corpus Uteri
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605537119 | ||
| 003 | CHVBK | ||
| 005 | 20210128100855.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20151201xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-3152-x |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-3152-x | ||
| 245 | 0 | 0 | |a Expression of B23/Nucleophosphamine Nonribosomal Nucleolar Protein in Smooth Muscle Tumors of the Corpus Uteri |h [Elektronische Daten] |c [A. Avdalyan, D. Kobyakov, V. Klimachev, I. Bobrov, A. Lazarev, A. Pichigina, E. Lushnikova, L. Nepomnyashchikh] |
| 520 | 3 | |a Immunohistochemical study of B23/nucleophosmine (NPM), the key argyrophilic nonribosomal protein associated with the nucleolus-producing regions, in smooth muscle formations of the body of the uterus and myometrium was carried out. The uterus index, number of positively stained nucleoli in the nucleus, integral optical density, and area of positively stained nucleoli were studied by computer-aided image analysis. The results indicated significant differences in the integral optical density and less so in the areas of NPM+ nucleoli in leiomyosarcomas, but not in intact myometrium and leiomyomas. Coefficients of variations in the integral optical density and NPM area proved to be significant parameters for differentiating leiomyosarcomas by size (≤7 cm or larger), evaluating the malignancy grade and stage of the process. NPM parameters in leiomyomas and leiomyosarcomas differed significantly, depending on the levels of Ki-67 and p53 expression and the receptor status of leiomyosarcoma. The index of area and the integral optical density of NPM could serve a accessory objective differential diagnostic criteria in cellular and mitotically active liomyomas and well-differentiated leiomyosarcoma of the corpus uteri. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a leiomyoma and leiomyosarcoma of the corpus uteri |2 nationallicence | |
| 690 | 7 | |a nucleophosmine |2 nationallicence | |
| 690 | 7 | |a immunohistochemistr |2 nationallicence | |
| 700 | 1 | |a Avdalyan |D A. |u Altai Affiliated Department of N. N. Blokhin Russian Cancer Research Center, Barnaul, Russia |4 aut | |
| 700 | 1 | |a Kobyakov |D D. |u Altai Affiliated Department of N. N. Blokhin Russian Cancer Research Center, Barnaul, Russia |4 aut | |
| 700 | 1 | |a Klimachev |D V. |u Altai State Medical University, Barnaul, Russia |4 aut | |
| 700 | 1 | |a Bobrov |D I. |u Altai State Medical University, Barnaul, Russia |4 aut | |
| 700 | 1 | |a Lazarev |D A. |u Altai Affiliated Department of N. N. Blokhin Russian Cancer Research Center, Barnaul, Russia |4 aut | |
| 700 | 1 | |a Pichigina |D A. |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia |4 aut | |
| 700 | 1 | |a Lushnikova |D E. |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia |4 aut | |
| 700 | 1 | |a Nepomnyashchikh |D L. |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia |4 aut | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 160/2(2015-12-01), 286-290 |x 0007-4888 |q 160:2<286 |1 2015 |2 160 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-3152-x |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-3152-x |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Avdalyan |D A. |u Altai Affiliated Department of N. N. Blokhin Russian Cancer Research Center, Barnaul, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Kobyakov |D D. |u Altai Affiliated Department of N. N. Blokhin Russian Cancer Research Center, Barnaul, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Klimachev |D V. |u Altai State Medical University, Barnaul, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Bobrov |D I. |u Altai State Medical University, Barnaul, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Lazarev |D A. |u Altai Affiliated Department of N. N. Blokhin Russian Cancer Research Center, Barnaul, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Pichigina |D A. |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Lushnikova |D E. |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Nepomnyashchikh |D L. |u Institute of Molecular Pathology and Pathomorphology, Novosibirsk, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 160/2(2015-12-01), 286-290 |x 0007-4888 |q 160:2<286 |1 2015 |2 160 |o 10517 | ||